Services we offer
Types of cancer we treat
We also treat bladder cancer, cancer of unknown primary, liver cancer, gallbladder and bile duct cancer, pancreatic cancer, skin cancer, trophoblastic disease and urological cancers.
Why choose us?
Through ongoing research, education and innovation, specialists at Imperial College Healthcare NHS Trust are at the leading edge of medical, surgical and radiation/clinical oncology, embracing the latest technology and international best-practices and setting standards for patient care.
We offer state of the art facilities and a calm, modern environment designed to support a personal and holistic approach to your care. You can be assured of professional care from every member of the team.
Research and innovation
Imperial College Healthcare NHS Trust is the UK’s first Academic Health Science Centre, and our specialists are actively engaged in education and research and at the forefront of their fields. This means that you benefit from access to the latest advances in clinical practice. We have research and clinical trials in progress all the time. There is a dedicated phase one clinical trials unit to test new cancer drugs at Hammersmith Hospital in the Sir John McMichael Centre. Many of our clinical trials are only in progress here at Imperial College Healthcare and we are committed to bringing our findings into clinical practice as quickly as possible.
Patient testimonial
"The nurses were fantastic, nothing was too much of a problem for them and they were all happy to help. They showed empathy, care and provided help and assistance above what I was expecting."
Cancer patient at Thames View, Charing Cross Hospital, June 2025
Patient testimonial
"The oncology nurses were always calm, welcoming, friendly and managed to make me feel comfortable. They worked hard to take good care of me."
Cancer patient at Thames View, Charing Cross Hospital, May 2025
Patient testimonial
"Very engaged staff, receptive to all queries, responded to all concerns, engaging other members of the team where necessary. All members of the team have been excellent."
Cancer patient at Thames View, Charing Cross Hospital, January 2025

